Leverage cyber threat intelligence to stay ahead of cyberattacks
Clinical Research Organizations: M&A Goldmine or Data Liability? Why Cybersecurity Must Be on Every Investor’s Radar
By: Jon Moore MS, JD, HCISPP, Chief Risk Officer and SVP Consulting- Clearwater The market for clinical trials is experiencing significant momentum in mergers and acquisitions (M&A). Private equity (PE) investment in Clinical Research Organizations (CROs) and Site...
Background Check, Drug Testing Firm Hack Affects 3.3 Million